Fredman B, Shapiro A, Zohar E, Feldman E, Shorer S, Rawal N, Jedeikin R
Department of Anesthesiology and Intensive Care, Meir Hospital, Kfar Saba. Orebro Medical Center Hospital, Orebro, Sweden.
Anesth Analg. 2000 Dec;91(6):1436-40. doi: 10.1097/00000539-200012000-00025.
To assess the efficacy and safety of wound instillation of ropivacaine, when administered via a patient-controlled elastometric pump, 50 term parturients undergoing cesarean delivery were enrolled into this prospective, placebo-controlled, double-blinded study. In all cases, a standard spinal anesthetic was administered. After the surgery, a multihole 20-gauge epidural catheter (B. Braun, Melsungen, Germany) was placed above the fascia such that the tip was sited at the point that demarcated 50% of the length of the surgical wound. Thereafter, the catheter was connected to the elastometric pump. According to a computer-generated randomization schedule, the pump was filled with either ropivacaine 0.2% (Ropivacaine Group) or an equal volume of sterile water (Control Group). Postoperatively, patient-controlled analgesia was administered via the elastometric pump. During the first 6 postoperative hours, a coinvestigator administered "rescue" morphine (2 mg, IV). Thereafter, "rescue" dipyrone (1 g) was administered on patient request. In a subset of 10 patients, blood ropivacaine levels were assessed. Compared with the Control Group, significantly fewer patients in the Ropivacaine Group received "rescue" morphine (92% vs. 48%, respectively) (P<0.01). The total "rescue" morphine administered during the first 6 postoperative hours was 2+/-3 mg vs. 10+/-5 mg (P<0.01) for the Ropivacaine and Control Groups, respectively. Patient-generated resting pain scores were similar between the groups. However, pain scores generated after coughing and leg raise were significantly (P<0.04) less in the Ropivacaine Group. More patients in the Ropivacaine Group than in the Control Group described their analgesia as good or excellent. In the subset of patients (n = 10) studied, unbound ropivacaine blood levels were below the toxic threshold (600 ng/mL). However, blood ropivacaine accumulation was noted. All patients stated that the elastometric pump was easy to use. Ropivacaine wound instillation via an elastometric pump is a simple technique that provides safe and effective analgesia after cesarean delivery.
为评估通过患者自控弹性泵进行伤口滴注罗哌卡因的有效性和安全性,50名足月剖宫产产妇被纳入这项前瞻性、安慰剂对照、双盲研究。所有病例均采用标准脊麻。术后,将一根20号多孔硬膜外导管(德国梅尔松根贝朗公司生产)置于筋膜上方,使其尖端位于手术伤口长度50%的分界点处。此后,将导管连接到弹性泵上。根据计算机生成的随机分组方案,弹性泵中填充0.2%罗哌卡因(罗哌卡因组)或等体积的无菌水(对照组)。术后,通过弹性泵进行患者自控镇痛。术后前6小时,由一名共同研究者给予“补救”吗啡(2毫克,静脉注射)。此后,根据患者要求给予“补救”安乃近(1克)。在10名患者的亚组中,评估了罗哌卡因血药浓度。与对照组相比,罗哌卡因组接受“补救”吗啡的患者明显较少(分别为92%和48%)(P<0.01)。罗哌卡因组和对照组术后前6小时给予的“补救”吗啡总量分别为2±3毫克和10±5毫克(P<0.01)。两组患者静息时的疼痛评分相似。然而,罗哌卡因组咳嗽和抬腿后的疼痛评分明显较低(P<0.04)。罗哌卡因组中认为镇痛效果良好或优秀的患者比对照组更多。在研究的患者亚组(n = 10)中,未结合的罗哌卡因血药浓度低于中毒阈值(600纳克/毫升)。然而,发现罗哌卡因血药浓度有蓄积。所有患者均表示弹性泵易于使用。通过弹性泵进行罗哌卡因伤口滴注是一种简单的技术,可在剖宫产术后提供安全有效的镇痛。